Kalorya
  • Supplements
  • Workouts
  • Coaching
Blog
Log inSign up
Kalorya
Legal noticePrivacy policyHealth disclaimerAre you a coach?

© 2026 Kalorya

Food supplements should not be used as a substitute for a varied, balanced diet and a healthy lifestyle. The content of this site is for information only and does not replace medical advice.

ToolsSupplementsCoachLog in
HomeJournalAgendaCoachProfile
HomeClientsAgendaWorkoutsProfile
Dietary supplements · Citicoline
Limited evidence8 studies

Citicoline

A compound identical to a natural brain cell precursor, sold as a nootropic. Its most solid and recent trials involve stroke and traumatic brain injury, not the memory of a healthy person.

How we rate

“Strong” = several concordant meta-analyses or systematic reviews. “Moderate” = one synthesis, or several controlled trials. “Limited” = early trials only. The rating is about the quality of the studies, not about how useful the supplement is.

Citicoline is taken as a powder or capsules, never through food
Citicoline is taken as a powder or capsules, never through food

HowToGym · Unsplash

Benefits

  • On pooled data from more than 1370 patients who suffered a moderate-to-severe ischemic stroke (4 trials), complete recovery at 3 months is more frequent with oral citicoline (25.2%) than with placebo (20.2%), with a more pronounced effect at 2000 mg/day
  • A meta-analysis of 10 trials (nearly 2300 patients) after a stroke associates citicoline with a reduction in the risk of death or disability
  • In 40 patients with open-angle glaucoma, 1000 mg per day for 60 days improves retinal and cortical responses to light, a benefit partially maintained after stopping treatment
  • In about a hundred patients who suffered an acute stroke, a more pronounced reduction in brain lesion volume between week 1 and week 12 was observed with citicoline, associated with clinical improvement

Recommended dosage

Clinical trials use 500 to 2000 mg per day, under medical supervision (stroke, traumatic brain injury, glaucoma). No dosage regimen exists for lifestyle use in a healthy person.

How to take it

  • No dosage for a healthy person: the trials in this profile all involve sick patients (stroke, traumatic brain injury, glaucoma), under medical supervision.
  • Trial dosages: 500 to 2,000 mg per day orally, for 6 weeks to 90 days.
  • On dosage: in the pooled analysis of 4 trials after a stroke, the effect was more pronounced at 2,000 mg per day.

Precautions

Well tolerated in all trials, with no serious side effects reported. Above all: the largest and most recent trials are negative. In over 1200 patients who suffered a traumatic brain injury, the COBRIT trial found no difference between citicoline and placebo on functional and cognitive recovery at 90 and 180 days. In over 2000 patients who suffered an ischemic stroke, the international ICTUS trial also found no difference in recovery at 90 days. An earlier phase III trial, on nearly 900 patients, showed no significant difference on its primary endpoint. Finally, and this is the most important point for the use sold in supplements: none of the studies reviewed here involve a healthy person looking to improve their memory or concentration. All available literature concerns patients who suffered a stroke, traumatic brain injury or glaucoma, under medical supervision — nothing documents the daily "nootropic" use for which citicoline is sold as a dietary supplement.

Did you know?

One might think that citicoline is a complex synthetic drug, but it is actually a substance identical to a natural precursor already present in our cells, which simply breaks down into choline and cytidine before being reused by the brain.

What the studies say

  • This large-scale international trial (ICTUS) tested citicoline (intravenous then oral, up to 2000 mg/day) in over 2000 patients who suffered a moderate-to-severe ischemic stroke. After 90 days, no significant difference in recovery was observed between the citicoline group and the placebo group. The study concludes that, under these conditions, citicoline did not demonstrate efficacy in treating acute ischemic stroke.

    Dávalos A, Alvarez-Sabín J, Castillo J, Díez-Tejedor E, Ferro J, Martínez-Vila E, Serena J, Segura T, Cruz VT, Masjuan J, Cobo E, Secades JJ, International Citicoline Trial on acUte Stroke (ICTUS) trial investigators. — Lancet (London, England) (2012) — View the source study

For information only: not a substitute for medical advice. Dietary supplements are not a replacement for a varied, balanced diet. Learn more